Korean J Gastroenterol.  2023 Sep;82(3):127-136. 10.4166/kjg.2023.060.

Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis

Affiliations
  • 1Integrative Cancer Center, CHA Ilsan Medical Center, Goyang, Korea
  • 2Department of Oncology and Hematology, CHA Ilsan Medical Center, CHA University, Goyang, Korea
  • 3Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Korea
  • 4Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 5Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, Korea
  • 6Department of Internal Medicine, The Catholic University of Korea, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
  • 7Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 8Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
  • 9Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea
  • 10Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University School of Medicine, Seoul, Korea
  • 11Department of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 12Department of Gastroenterology, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea
  • 13Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
  • 14Division of Gastroenterology and Hepatology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 15Department of Gastroenterology and Hepatology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea

Abstract

Background/Aims
Chronic hepatitis C is a major risk factor for liver cirrhosis, hepatocellular carcinoma, and hepatic failure. Although traditional practices, including acupuncture, tend to increase the risk of HCV infection, the association remains controversial. Therefore, the current meta-analytical study was undertaken to evaluate the risks of acupuncture and hepatitis C transmission.
Methods
Two researchers independently screened studies from the databases encompassing the period from inception to May 12, 2022. Baseline demographics, HCV transmission OR, and 95% CIs were extracted, pooled, and analyzed using random-effect models. Subgroup analyses utilizing study design and ethnicity were performed. Heterogeneity and publication bias were analyzed using the Higgins I2 test and funnel plots, respectively.
Results
In all, 28 studies with 194,826 participants (178,583 controls [91.7%] vs. 16,243 acupuncture users [8.3%]) were included in the final analysis. The pooled analysis showed that acupuncture users had a significantly higher HCV transmission rate than controls with heterogeneity (OR, 1.84 [1.46–2.32]; p<0.001; I2 =80%). In the subgroup analysis, both cross-sectional case-control (n=14; OR, 1.96 [1.47–2.61]; p<0.001; I2 =88%) and cross-sectional studies (n=12; OR, 1.85 [1.32–2.61]; p<0.001; I2 =0%) showed significantly higher HCV infection rates in the acupuncture group than in the control group. Both Asian and non-Asian acupuncture users showed a higher HCV transmission risk than the controls (all Ps <0.001). No significant publication bias was observed.
Conclusions
Our findings indicate that acupuncture increases the risk of HCV transmission. Due to HCV's contagiousness, unsafe medical and social practices (including acupuncture) should be performed with caution.

Keyword

Acupuncture; Hepatitis C virus; Transmission; Meta-analysis

Figure

  • Fig. 1 Study flow chart.

  • Fig. 2 Pooled analysis of odds ratio for the association between acupuncture and HCV infection. Each dot represents the OR with a 95% CI. The box size represents the weight of the study in the meta-analysis. Weights were obtained using the random-forest model. M-H, Mantel-Haenszel.

  • Fig. 3 Pooled analysis of odds ratio for the association between acupuncture and HCV infection according to study design. Each dot represents the OR with a 95% CI. The box size represents the weight of the study in the meta-analysis. Weights were obtained using the random-forest model. M-H, Mantel-Haenszel.

  • Fig. 4 Pooled analysis of odds ratio for the association between acupuncture and HCV infection according to ethnicity. Each dot represents the OR with a 95% CI. The box size represents the weight of the study in the meta-analysis. Weights were obtained using the random-forest model. M-H, Mantel-Haenszel.

  • Fig. 5 Funnel plot for the association between acupuncture and HCV infection. SE, standard error.


Cited by  1 articles

침치료가 C형간염 전파 위험을 높일까? 최근 출간된 “침술과 C형간염 바이러스 전파 위험성: 체계적 문헌 고찰 및 메타분석”에 대한 의견
Tae-Hun Kim, Myeong Soo Lee, Hyangsook Lee
Korean J Gastroenterol. 2024;83(2):69-71.    doi: 10.4166/kjg.2023.134.


Reference

1. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016; 388:1081–1088. DOI: 10.1016/S0140-6736(16)30579-7. PMID: 27394647. PMCID: PMC5100695.
2. WHO. Hepatitis C world health organization key facts. [Internet]. WHO;cited 2023 Feb 28. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
3. Nelson PK, Mathers BM, Cowie B, et al. 2011; Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 378:571–583. DOI: 10.1016/S0140-6736(11)61097-0. PMID: 21802134. PMCID: PMC3285467.
4. El-Ghitany EM, Abdel Wahab MM, Abd El-Wahab EW, Hassouna S, Farghaly AG. 2015; A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): do they differ in Egypt? Liver Int. 35:489–501. DOI: 10.1111/liv.12617. PMID: 24923487.
5. Saks M. 1994. Professions and the public interest: medical power, altruism and alternative medicine. Routledge;London:
6. National Center for Complementary and Integrative Health. 2016. Acupuncture: What you need to know. [Internet]. NIH;Available from: https://www.nccih.nih.gov/health/acupuncture-what-you-need-to-know. cited 2022 Nov 15.
7. Brady S, McEvoy J, Dommerholt J, Doody C. 2014; Adverse events following trigger point dry needling: a prospective survey of chartered physiotherapists. J Man Manip Ther. 22:134–140. DOI: 10.1179/2042618613Y.0000000044. PMID: 25125935. PMCID: PMC4101552.
8. Mitrovic N, Delic D, Markovic-Denic L, et al. 2015; Seroprevalence and risk factors for hepatitis C virus infection among blood donors in Serbia: A multicentre study. Dig Liver Dis. 47:572–576. DOI: 10.1016/j.dld.2015.03.019. PMID: 25882212.
9. Rezaei N, Amini-Kafiabad S, Maghsudlu M, Abolghasemi H. 2016; Risk factor analysis of hepatitis C virus seropositivity in Iranian blood donors: a case-control study. Transfusion. 56:1891–1898. DOI: 10.1111/trf.13660. PMID: 27273657.
10. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. 2010; Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 14:e928–e940. DOI: 10.1016/j.ijid.2010.03.019. PMID: 20678951.
11. Lim SH, Lee S, Lee YB, et al. 2022; Increased prevalence of transfusion-transmitted diseases among people with tattoos: A systematic review and meta-analysis. PLoS One. 17:e0262990. DOI: 10.1371/journal.pone.0262990. PMID: 35085358. PMCID: PMC8794209.
12. Tohme RA, Holmberg SD. 2012; Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 54:1167–1178. DOI: 10.1093/cid/cir991. PMID: 22291098. PMCID: PMC4613802.
13. Van Remoortel H, Moorkens D, Avau B, Compernolle V, Vandekerckhove P, De Buck E. 2019; Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis. Vox Sang. 114:297–309. DOI: 10.1111/vox.12780. PMID: 30972765.
14. Modesti PA, Reboldi G, Cappuccio FP, et al. 2016; Panethnic differences in blood pressure in Europe: A systematic review and meta-analysis. PLoS One. 11:e0147601. DOI: 10.1371/journal.pone.0147601. PMID: 26808317. PMCID: PMC4725677.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003; Measuring inconsistency in meta-analyses. BMJ. 327:557–560. DOI: 10.1136/bmj.327.7414.557. PMID: 12958120. PMCID: PMC192859.
16. Egger M, Davey Smith G, Schneider M, Minder C. 1997; Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. DOI: 10.1136/bmj.315.7109.629. PMID: 9310563. PMCID: PMC2127453.
17. Salama BM. 2020; Risk factors associated with HCV infection among adults in Damietta Governorate, Egypt. Ann Clin Anal Med. 11:519–522. DOI: 10.4328/ACAM.20149.
18. Mohd Suan MA, Said SM, Lim PY, Azman AZF, Abu Hassan MR. 2019; Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case-control study. PLoS One. 14:e0224459. DOI: 10.1371/journal.pone.0224459. PMID: 31661525. PMCID: PMC6818779.
19. Wasitthankasem R, Vichaiwattana P, Siripon N, et al. 2018; Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy. PLoS One. 13:e0202991. DOI: 10.1371/journal.pone.0202991. PMID: 30138441. PMCID: PMC6107264.
20. Mac Donald-Ottevanger MS, Vreden S, van der Helm JJ, et al. 2016; Prevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname. Virology. 499:114–120. DOI: 10.1016/j.virol.2016.07.001. PMID: 27657832.
21. Sohn HS, Kim JR, Ryu SY, et al. 2016; Risk factors for hepatitis C virus (HCV) infection in areas with a high prevalence of HCV in the Republic of Korea in 2013. Gut Liver. 10:126–132. DOI: 10.5009/gnl14403. PMID: 26260752. PMCID: PMC4694744.
22. Huang P, Zhu LG, Zhai XJ, et al. Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012. Epidemiol Infect. 2015; 143:2827–2836. DOI: 10.1017/S0950268814003719. PMID: 25600557. PMCID: PMC9151013.
23. Huang Y, Guo N, Yu Q, et al. 2015; Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers. Transfusion. 55:388–394. DOI: 10.1111/trf.12850. PMID: 25382751.
24. Carney K, Dhalla S, Aytaman A, Tenner CT, Francois F. 2013; Association of tattooing and hepatitis C virus infection: a multicenter case-control study. Hepatology. 57:2117–2123. DOI: 10.1002/hep.26245. PMID: 23315899.
25. Kin KC, Lin B, Ha NB, et al. 2013; High proportion of hepatitis C virus in community Asian American patients with non-liver-related complaints. J Clin Gastroenterol. 47:367–371. DOI: 10.1097/MCG.0b013e3182688b3e. PMID: 23090039.
26. Seong MH, Kil H, Kim YS, et al. 2013; Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol. 85:1724–1733. DOI: 10.1002/jmv.23661. PMID: 23813472.
27. Ahmed F, Irving WL, Anwar M, Myles P, Neal KR. 2012; Prevalence and risk factors for hepatitis C virus infection in Kech District, Balochistan, Pakistan: most infections remain unexplained. A cross-sectional study. Epidemiol Infect. 140:716–723. DOI: 10.1017/S0950268811001087. PMID: 21672295.
28. Kim JY, Cho J, Hwang SH, et al. 2012; Behavioral and healthcare-associated risk factors for chronic hepatitis C virus infection in Korea. J Korean Med Sci. 27:1371–1377. DOI: 10.3346/jkms.2012.27.11.1371. PMID: 23166420. PMCID: PMC3492673.
29. He Y, Zhang J, Zhong L, et al. 2011; Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China. J Med Virol. 83:616–621. DOI: 10.1002/jmv.22010. PMID: 21328375.
30. Vickery K, Tawk HM, Bisset L, Selby W, Cossart YE. 2009; Hepatitis C virus infection rates and risk factors in an Australian hospital endoscopy cohort. Aust N Z J Public Health. 33:442–448. DOI: 10.1111/j.1753-6405.2009.00426.x. PMID: 19811480.
31. Nguyen VT, McLaws ML, Dore GJ. 2007; Prevalence and risk factors for hepatitis C infection in rural north Vietnam. Hepatol Int. 1:387–393. DOI: 10.1007/s12072-007-9008-3. PMID: 19669334. PMCID: PMC2716832.
32. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G. 2006; A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat. 13:775–782. DOI: 10.1111/j.1365-2893.2006.00742.x. PMID: 17052278.
33. Méndez-Sánchez N, Motola-Kuba D, Zamora-Valdés D, et al. 2006; Risk factors and prevalence of hepatitis virus B and C serum markers among nurses at a tertiary-care hospital in Mexico City, Mexico: a descriptive study. Ann Hepatol. 5:276–280. DOI: 10.1016/S1665-2681(19)31988-X. PMID: 17151581.
34. Dominitz JA, Boyko EJ, Koepsell TD, et al. 2005; Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 41:88–96. DOI: 10.1002/hep.20502. PMID: 15619249.
35. Hand WL, Vasquez Y. 2005; Risk factors for hepatitis C on the Texas-Mexico border. Am J Gastroenterol. 100:2180–2185. DOI: 10.1111/j.1572-0241.2005.00238.x. PMID: 16181366.
36. Yildirim B, Tahan V, Ozaras R, et al. 2005; Hepatitis C virus risk factors in the Turkish community. Dig Dis Sci. 50:2352–2355. DOI: 10.1007/s10620-005-3061-3. PMID: 16416188.
37. Lee PL, Wang JH, Tung HD, Lee CM, Lu SN. 2004; A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan. Trans R Soc Trop Med Hyg. 98:367–372. DOI: 10.1016/j.trstmh.2003.10.013. PMID: 15099993.
38. Brandão AB, Fuchs SC. 2002; Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol. 2:18. DOI: 10.1186/1471-230X-2-18. PMID: 12169200. PMCID: PMC122085.
39. Brillman JC, Crandall CS, Florence CS, Jacobs JL. 2002; Prevalence and risk factors associated with hepatitis C in ED patients. Am J Emerg Med. 20:476–480. DOI: 10.1053/ajem.2002.32642. PMID: 12216048.
40. Kim YS, Ahn YO, Lee HS. 2002; Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci. 17:187–192. DOI: 10.3346/jkms.2002.17.2.187. PMID: 11961301. PMCID: PMC3054844.
41. Shin HR, Kim JY, Kim JI, et al. 2002; Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. Br J Cancer. 87:314–318. DOI: 10.1038/sj.bjc.6600436. PMID: 12177801. PMCID: PMC2364222.
42. Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L. 2001; Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol. 65:688–693. DOI: 10.1002/jmv.2091. PMID: 11745932.
43. Haley RW, Fischer RP. 2001; Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore). 80:134–151. DOI: 10.1097/00005792-200103000-00006. PMID: 11307589.
44. Müller Z, Deák J, Horányi M, et al. 2001; The detection of hepatitis C virus in South Hungary. J Clin Virol. 20:81–83. DOI: 10.1016/S1386-6532(00)00159-1. PMID: 11163587.
45. Vickers AJ, Cronin AM, Maschino AC, et al. 2012; Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med. 172:1444–1453. DOI: 10.1001/archinternmed.2012.3654. PMID: 22965186. PMCID: PMC3658605.
46. Langevin HM, Schnyer R, MacPherson H, et al. 2015; Manual and electrical needle stimulation in acupuncture research: pitfalls and challenges of heterogeneity. J Altern Complement Med. 21:113–128. DOI: 10.1089/acm.2014.0186. PMID: 25710206. PMCID: PMC4855731.
47. Luo J, Xu H, Liu B. 2015; Real world research: a complementary method to establish the effectiveness of acupuncture. BMC Complement Altern Med. 15:153. DOI: 10.1186/s12906-015-0676-6. PMID: 25997850. PMCID: PMC4440554.
48. Raffaele A, Valenti M, Iovenitti M, et al. 2001; High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol. 17:41–46. DOI: 10.1023/A:1010932832190. PMID: 11523574.
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr